Previous close | 1.4000 |
Open | 1.4000 |
Bid | 1.8000 |
Ask | 2.4500 |
Strike | 30.00 |
Expiry date | 2025-01-17 |
Day's range | 1.4000 - 1.4000 |
Contract range | N/A |
Volume | |
Open interest | 103 |
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript May 7, 2024 Apellis Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.54 EPS, expectations were $-0.54. Apellis Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good […]
Apellis Pharmaceuticals ( NASDAQ:APLS ) First Quarter 2024 Results Key Financial Results Revenue: US$172.3m (up 284...
Discover how Apellis Pharmaceuticals Inc navigated Q1 2024 with significant revenue increases and strategic advancements despite competitive challenges.